Plasma CAMK2A predicts chemotherapy resistance in metastatic triple negative breast cancer

Background: Chemotherapy resistance is a great obstacle in effective treatment for metastatic triple negative breast cancer (TNBC). The ability to predict chemotherapy response would allow chemotherapy administration to be directed toward only those patients who would benefit, thus maximizing treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Clin Exp Pathol
Main Authors: Shao, Bin, Tian, Zhihua, Ding, Huirong, Wang, Qingsong, Song, Guohong, Di, Lijun, Zhang, Hong, Li, Huiping, Shen, Jing
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6958019/
https://ncbi.nlm.nih.gov/pubmed/31938151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados